Vium

Vium is a translational medicine company focused on improving the success of drug development.  Through the creation of more precise and reproducible disease models, Vium’s digital platform provides physiological biomarkers that enable better decisions on which compounds should be advanced to the clinic.  

Vium’s Digital Vivarium™ and Vium Cloud is the gold-standard in vivo platform combining computer vision, artificial intelligence, machine learning and sensor technology to non-invasively collect and derive insights from digital biomarkers.  The Vium platform continuously captures physiological metrics and behaviors non-invasively, providing more sensitive and  accurate data collection, leading to more replicable studies.  By providing researchers with these continuous, rich data sets, the platform enables them to identify which digital biomarkers, or combinations of biomarkers, are the strongest indicators of disease.  

Founded in 2013, Vium’s team includes experienced scientists and software and hardware engineers, with multi-disciplinary expertise in biology, pharmaceutical R&D, artificial intelligence, algorithm design, hardware devices and in vivo science.  Our customers include pharmaceutical and biotechnology companies, academic researchers and novel therapeutic discovery and development labs.